Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 250

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

1,415.00p
   
  • Change Today:
      7.50p
  • 52 Week High: 1,618.00p
  • 52 Week Low: 855.60p
  • Currency: UK Pounds
  • Shares Issued: 241.42m
  • Volume: 31,804
  • Market Cap: £3,416.06m
  • RiskGrade: 176
  • Beta: 0.00

Latest Deals

Traded Action Notifier PriceAmountValue
30-May-18 Buy Sigurdur Olafsson 1,309.19p 20,000 £261,838.00

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
30-May-18 Buy Sigurdur Olafsson 1,309.19p 20,000 £261,838.00

Director Shareholdings

Notifier Holding Value*
Said Darwazah 15,051,708 £212,981,668
Ali Al-Husry 7,118,180 £100,722,247
Mazen Darwazah 3,470,559 £49,108,410
Khalid Nabilsi 244,265 £3,456,350
Ronald L Goode 12,000 £169,800
Robert Pickering 10,000 £141,500
Pat Butler 3,875 £54,831
John J. Castellani 3,500 £49,525
Pamela Kirby 3,317 £46,936

Major Shareholders

Notifier** Holding Value*
Darhold Limited 60,000,000 £849,000,000
Boehringer Ingelheim Corporation; 40,000,000 £566,000,000
The Capital Group Companies, Inc 26,511,744 £375,141,178
Capital Group International 24,161,331 £341,882,834
DuPont Capital Management Corporation 19,232,981 £272,146,681
Strategic Equity Capital Plc 9,791,950 £138,556,092
Fidelity International 9,791,950 £138,556,092
Vanguard Healthcare Fund 7,284,981 £103,082,481

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,415.00p
Change Today 7.50p
% Change 0.53 %
52 Week High 1,618.00p
52 Week Low 855.60p
Volume 31,804
Shares Issued 241.42m
Market Cap £3,416.06m
Beta 0.00
RiskGrade 176

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.93% below the market average32.93% below the market average32.93% below the market average32.93% below the market average32.93% below the market average
80.95% above the sector average80.95% above the sector average80.95% above the sector average80.95% above the sector average80.95% above the sector average
Price Trend
26% below the market average26% below the market average26% below the market average26% below the market average26% below the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average
Income
53.12% below the market average53.12% below the market average53.12% below the market average53.12% below the market average53.12% below the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
77.15% below the market average77.15% below the market average77.15% below the market average77.15% below the market average77.15% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 6
Sell 1
Strong Sell 2
Total 13
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 05-Apr-18 24-Aug-17
Paid 24-May-18 22-Sep-17
Amount 23.00¢ 11.00¢

Trades for 21-Jun-2018

Time Volume / Share Price
09:08 100 @ 1,415.00p
09:08 200 @ 1,415.00p
09:08 12 @ 1,414.00p
09:08 110 @ 1,414.00p
09:08 141 @ 1,415.00p

HIK Key Personnel

CFO Khalid Nabilsi
CEO Sigurdur Olafsson

Top of Page